True Wealth Design
MYGN icon

True Wealth Design’s Myriad Genetics MYGN Stock Holding History

True Wealth Design’s Portfolio MYGN Stock Details MYGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$3.11K Sell
722
-1,404
-66% -$5.92K ﹤0.01% 1519
2026
Q2 		$12.1K Buy
2,126
+1,019
+92% +$4.62K ﹤0.01% 995
2026
Q1 		$4.98K Sell
1,107
-342
-24% -$1.78K ﹤0.01% 1212
2025
Q4 		$8.91K Buy
1,449
+74
+5% +$537 ﹤0.01% 903
2025
Q3 		$9.9K Sell
1,375
-339
-20% -$2.01K ﹤0.01% 835
2025
Q2 		$9.1K Buy
1,714
+1,116
+187% +$6.59K ﹤0.01% 617
2025
Q1 		$5.3K Buy
598
+480
+407% +$5.76K ﹤0.01% 667
2024
Q4 		$1.62K Buy
+118
New +$2.18K ﹤0.01% 793

Other funds holding MYGN

Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $85.7B AUM 51.02% 1-Year Est. Return
Mackenzie Financial
Mackenzie Financial Toronto Ontario, Ontario, Canada $91.6B AUM 30% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Connor, Clark & Lunn Investment Management (CC&L)
Connor, Clark & Lunn Investment Management (CC&L) Vancouver, British Columbia, Canada $57.2B AUM 42.49% 1-Year Est. Return
Nuveen
Nuveen Charlotte, North Carolina $420B AUM 34.97% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $103B AUM 40.17% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return
OP Asset Management
OP Asset Management Helsinki $11.8B AUM 34.59% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return

True Wealth Design's MYGN Position: Q3 2026 in Review

True Wealth Design reduced its Myriad Genetics (MYGN) stake by 66% in Q3 2026, selling an estimated $5.92K and leaving 722 shares worth $3.11K. The position accounts for ﹤0.01% of the portfolio, ranked #1519.

True Wealth Design first reported a position in MYGN in Q4 2024 and has held it in 8 quarters since. The position peaked at $12.1K in Q2 2026. 79 funds tracked by Wall St. Rank hold MYGN as of Q3 2026.

  • True Wealth Design held 722 shares of Myriad Genetics worth $3.11K as of Q3 2026.
  • True Wealth Design sold 1,404 Myriad Genetics shares in Q3 2026, an estimated $5.92K.
  • Myriad Genetics made up ﹤0.01% of True Wealth Design's portfolio in Q3 2026, its #1519 holding.
  • True Wealth Design first reported a position in Myriad Genetics in Q4 2024 and has held it in 8 quarters since.
  • True Wealth Design's Myriad Genetics position peaked at $12.1K in Q2 2026.
  • 79 funds tracked by Wall St. Rank held Myriad Genetics as of Q3 2026.

Based on True Wealth Design's 13F filing for Q3 2026, filed 13 Oct 2026.